Autopsy report · NCT00919126

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

“Enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 7 months before it stopped.
• 102 participants enrolled.
• Results were posted on the registry 2 years 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Air Liquide SA

Sponsor type

Industry

Conditions

Anaesthesia

Interventions

Xenon; Xenon; Medical Air in Oxygen

Participants

102

Sites

6

Countries

France, Germany, United Kingdom

Trials that died the same way

• Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
  “Low enrollment rate” (85% match in meaning)
• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (83% match in meaning)
• Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
  “Lower than anticipated rate of subject enrollment” (81% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (80% match in meaning)
• Development of a NIPTT for Detecting Copy Number Variations
  “Poor rate of eligible subject enrollment” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.